ALPS ETF TR - MED BREAKTHGH (SBIO)

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / MED BREAKTHGH
Number of holders
35
Total 13F shares, excl. options
1,344,986
Shares change
-60,935
Total reported value, excl. options
$36,611,445
Value change
-$2,061,644
Put/Call ratio
34%
Number of buys
15
Number of sells
15
Price
$27.22

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q3 2023

As of 30 Sep 2023 ALPS ETF TR - MED BREAKTHGH (SBIO) had 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 1,344,986 shares of stock of the company.
Largest 10 holders included DAVENPORT & Co LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, Strategic Financial Services, Inc,, WELLS FARGO & COMPANY/MN, NTV Asset Management LLC, Royal Bank of Canada, CITADEL ADVISORS LLC, and LPL Financial LLC.
This table shows 35 institutional shareholders of the security as of 30 Sep 2023.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.